Fulminant hepatic failure after the start of an efavirenz-based HAART regimen in a treatment-naive female AIDS patient without hepatitis virus co-infection.
Abrescia
Nicola
N
D'Abbraccio
Maurizio
M
Figoni
Mario
M
Busto
Annunziata
A
Butrico
Ettore
E
De Marco
Mario
M
Viglietti
Rosaria
R
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy*; D000328:Adult; D000480:Alkynes; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D048588:Benzoxazines; D003521:Cyclopropanes; D005260:Female; D015497:HIV-1 / Q000187:drug effects; D006525:Hepatitis, Viral, Human / Q000150:complications / Q000188:drug therapy / Q000821:virology*; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced* / Q000503:physiopathology; D010078:Oxazines / Q000009:adverse effects*
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; C098320:efavirenz